The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways

The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways

Bibliographic Details
Main Authors:	Suda, T, Takahashi, N, Udagawa, N, Miyaura, C
Format:	Online
Language:	English
Published:	BioMed Central 2001
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273194/

Similar Items

Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
by: Kobayashi, Kanichiro, et al.
Published: (2000)

The molecular mechanism of osteoclastogenesis in rheumatoid arthritis
by: Udagawa, Nobuyuki, et al.
Published: (2002)

RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin
by: Sung, Bokyung, et al.
Published: (2013)

RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
by: Kukita, Toshio, et al.
Published: (2004)

TRPM7 Is Essential for RANKL-Induced Osteoclastogenesis
by: Yang, Yu-Mi, et al.
Published: (2013)

Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
by: Kim, Jeong Yeon, et al.
Published: (2012)

Activation of G Proteins by Aluminum Fluoride Enhances RANKL-Mediated Osteoclastogenesis
by: Park, Boryung, et al.
Published: (2013)

Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
by: Song, Min-Kyoung, et al.
Published: (2015)

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
by: Erkhembaatar, Munkhsoyol, et al.
Published: (2015)

Infection of RANKL-Primed RAW-D Macrophages with Porphyromonas gingivalis Promotes Osteoclastogenesis in a TNF-α-Independent Manner
by: Kukita, Akiko, et al.
Published: (2012)

Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL
by: Xing, Rui, et al.
Published: (2016)

Acteoside Suppresses RANKL-Mediated Osteoclastogenesis by Inhibiting c-Fos Induction and NF-κB Pathway and Attenuating ROS Production
by: Lee, Seung-Youp, et al.
Published: (2013)

LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42
by: Ye, Shiqiao, et al.
Published: (2016)

The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis
by: Wang, Wengang, et al.
Published: (2014)

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
by: Shen, Yi, et al.
Published: (2015)

Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes
by: Kanzaki, Hiroyuki, et al.
Published: (2016)

Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis
by: Zhao, Dongfeng, et al.
Published: (2014)

Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
by: Albers, Joachim, et al.
Published: (2013)

Effects of Inositol 1,4,5-triphosphate on Osteoclast Differentiation in RANKL-induced Osteoclastogenesis
by: Son, Aran, et al.
Published: (2012)

Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In Vivo
by: Ai, Li-Sha, et al.
Published: (2012)

Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling
by: Xia, Wen-Fang, et al.
Published: (2013)

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis
by: Tseng, Feng-Jen, et al.
Published: (2014)

Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation
by: Qiang Zhang, et al.
Published: (2018-09-01)

Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo
by: Cheng-Ming Wei, et al.
Published: (2018-07-01)

Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo
by: Chen, Shuai, et al.
Published: (2015)

Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1
by: Chen, Yueqi, et al.
Published: (2016)

STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis
by: Lee, Jongwon, et al.
Published: (2016)

Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells
by: Zeng, Yan-Ping, et al.
Published: (2016)

Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL
by: Kassem, Ali, et al.
Published: (2016)

MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone
by: Wang, Ting, et al.
Published: (2015)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
by: Quan, Gui-Hua, et al.
Published: (2015)

The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice
by: Vinik, Yaron, et al.
Published: (2015)

Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations
by: Herbert, Bethany A., et al.
Published: (2015)

PKCβ Positively Regulates RANKL-Induced Osteoclastogenesis by Inactivating GSK-3β
by: Shin, Jihye, et al.
Published: (2014)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
by: Kang, Moo Rim, et al.
Published: (2014)

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells
by: Kong, Lingbo, et al.
Published: (2014)

Aminothiazoles inhibit RANKL‐ and LPS‐mediated osteoclastogenesis and PGE 2 production in RAW 264.7 cells
by: Kats, Anna, et al.
Published: (2016)

Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity
by: Hur, Jeonghwan, et al.
Published: (2016)

Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities
by: Joung, Youn Hee, et al.
Published: (2016)

Molecular Signaling Pathways Mediating Osteoclastogenesis Induced by Prostate Cancer Cells
by: Rafiei, Shahrzad, et al.
Published: (2013)